Study criticisms unjustified [2]

Environmental Health Perspectives

Volumn 112, Issue 3, 2004, Pages

  Chart, Ian S ^a   Manley, Ann ^a   Youngren, Susan Hunter ^b  

^a AMVAC Chemical Corporation   (United States)

^b Acta Group LLC   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE; DICHLORVOS;

ANALYTIC METHOD; CHOLINESTERASE INHIBITION; ENVIRONMENTAL HEALTH; ENVIRONMENTAL MANAGEMENT; ENVIRONMENTAL PROTECTION; GOOD CLINICAL PRACTICE; GOOD LABORATORY PRACTICE; HEALTH HAZARD; HUMAN; LETTER; MEDICAL ETHICS; PRIORITY JOURNAL; RISK ASSESSMENT; TOXICITY TESTING; VALIDATION PROCESS; WORLD HEALTH ORGANIZATION;

EID: 1542498438     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (24)

1. AMVAC. 1997. Dichlorvos: A Single Blind, Placebo Controlled, Randomized Study to Investigate the Effects of Multiple Oral Dosing on Erythrocyte Cholinesterase Inhibition in Healthy Male Volunteers. Report No. CTL/P5392. Study No. XH6063. MRID No. 442488-01. Newport Beach, CA:AMVAC Chemical Corporation.
2. Cervoni WA, Oliver-Gonzalez J, Kaye S, Slomka MB. 1969. Dichlorvos as a single-dose intestinal anthelmintic therapy for man. Am J Trop Med Hyg 18(6): 912-919.
3. European Commission. 1986. 87/18/EEC Council Directive of 18 December 1986 on the Harmonization of Laws, Regulations and Administrative Provisions Relating to the Application of the Principles of Good Laboratory Practice and the Verification of Their Applications for Tests on Chemical Substances. Brussels:EUropean Commission. Available: Http://europa.eu.int/smartapi/cgi/sga_doc?smartapi! celexapi! prod! CELEXnumdoc&lg=en&numdoc=31987L0018&model=guichett [accessed 16 December 2003].
4. European Commission. 1988. 88/320/EEC Council Directive of 9 June 1988 on the Inspection and Verification of Good Laboratory Practice. Brussels:EUropean CommissHon. Available: http:// europa.eu.int/smartapi/cgi/sga_doc?smartapi!celexapi! prodlCELEXnumdoc&lg=en&numdoc=31988L0320& model=guichett [accessed 16 December 2003].
5. Funckes AJ, Miller S, Hayes W. 1963. Initial field studies in Upper Volta with dichlorvos residual fumigant as a malaria eradication technique. Bull WHO 29:243-246.
6. Gallo MA, Lawryk NJ. 1991. Organic phosphorus pesticides. In: Handbook of Pesticide Toxicology, Vol 12 (Hayes WJ, Laws ER, eds). San Diego, CA:ACademic Press, 917-1123.
7. Her Majesty's Stationary Office. 1999. Statutory Instrument 1999 No. 3106, Health and Safety, The Good Laboratory Practice Regulations 1999. Available: Http://www.hmso.gov.uk/ si/si1999/19993106.htm [accessed 16 December 2003].
8. IPCS. 2002. Report of the Meeting on Bridging the Gap Between Clinical and Regulatory Toxicology. Geneva:INternational Programme on Chemical Safety. Available: Http://www.who.int/pcs/emerg_site/hdi/Bridging_Gap_Final%20Report.pdf [accessed 16 December 2003].
9. Lotti M. 2001. Clinical toxicology of anticholinesterase agents in humans. In: Handbook of Pesticide Toxicology, Vol 2 (Krieger R, ed). San Diego, CA:ACademic Press, 1043-1085.
10. Menz M, Luetkemeier H, Sachsse K. 1974. Long-term exposure of factory workers to dichlorvos (DDVP) insecticide. Arch Environ Health 28: 72-76.
11. OECD. 1998. OECD Series on Principles of Good Laboratory Practice and Compliance Monitoring Number 1: OECD Principles on Good Laboratory Practice (as revised in 1997). Paris:ORganisation for Economic Co-operation and Development. Available: Http://www.olis.oecd.org/olis/ 1998doc.nsf/LinkTo/env-mc-chem(98)17 [accessed 9 February 2004].
12. Olson H, Betton G, Robinson D, Thomas K, Monro A, Kolaja G, et al. 2000. Concordance of the toxicity of pharmaceuticals in humans and in animals. Regul Toxicol Pharmacol 32:58-67.
13. Pena Chavarria A, Swartzwelder JC, Villarejos VM, Kotcher E, Arguedas J. 1969. Dichlorvos, an effective broad-spectrum anthelmintic. Am J Trop Med Hyg 18(6):907-911.
14. Slomka MB, Hine CH. 1981. Clinical pharmacology of dichlorvos. Acta Pharmacol Toxicol 49 (suppl V):105-108.
15. U.S. EPA. 1989. Toxicity assessment. In: Risk Assessment Guidance for Superfund (RAGS) Part A. EPA/540/1-89/002. Washington, DC:U.S. Environmental Protection Agency, 7-1-7-23. Available: http://www.epa.gov/superfund/ programs/risk/ragsa/ch7.pdf [accessed 16 December 2003].
16. U.S. EPA. 1993. Reference Dose (RfD): Description and Use in Health Risk Assessments. Washington, DC:U.S. Environmental Protection Agency. Available: Http:// www.epa.gov/iris/rfd.htm [accessed 16 December 2003].
17. U.S. EPA. 1994. Methods for Derivation of Inhalation Reference Concentrations and Application of Inhalation Dosimetry. EPA/600/8-90-066F. Washington, DC:U.S. Environmental Protection Agency, Office of Health and Environmental Assessment.
18. U.S. EPA. 1998. Memorandum from JE Stewart, Registration Action Branch II, to C Scheltema, Risk Characterization and Analysis Branch. Review of Toxicity Studies on DDVP Using Human Volunteers (Data Evaluation Reports for MRID Nos. 44317901, 442488-01, and 442488-02). Washington, DC:U.S. Environmental Protection Agency.
19. U.S. EPA. 2002. A Review of the Reference Dose and Reference Concentration Processes. EPA/630/P-02/002F. Washington, DC: U.S. Environmental Protection Agency. Available: Http:// cfpub.epa.gov/ncea/cfm/recordisplay.cfm?deid=55365 [accessed 16 December 2003].
20. U.S. EPA. 2003. Draft Final Guidelines for Carcinogen Risk Assessment. Washington, DC:U.S. Environmental Protection Agency. Available: Http://oaspub.epa.gov/ eims/eimscomm.getfile?p_download_id=36765 [accessed 16 December 2003].
21. WHO. 1986. Organophosphorus Insecticides: A General Introduction. Environmental Health Criteria 63. Geneva:WOrld Health Organization. Available: Http:// www.inchem.org/documents/ehc/ehc/ehc83.htm [accessed 16 December 2003].
22. WHO. 1994. Assessing Human Health Risks of Chemicals: Derivation of Guidance Values for Health-Based Exposure Limits. Environmental Health Criteria 170. Geneva:WOrld Health Organization. Available: Http://www.inchem.org/ documents/ehc/ehc/ ehc170.htm [accessed 16 December 2003].
23. WHO. 2001. Neurotoxicity Risk Assessment for Human Health: Principles and Approaches. Environmental Health Criteria 223. Geneva:WOrld Health Organization. Available: http://www.inchem.org/documents/ehc/ehc/ ehc223.htm [accessed 16 December 2003].
24. World Medical Association. 2002. World Medical Association Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects. Available: Http:// www.wma.net/e/policy/b3.htm [accessed 16 December 2003].